REGINA STANLEY: Open Payments
NPI 1134682164 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 25 payments from 11 companies in 2025. Trend: 2023 $282 · 2024 $587 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $327 |
| Novo Nordisk Inc | 5 | $261 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $147 |
| Phathom Pharmaceuticals, Inc. | 3 | $124 |
| AstraZeneca Pharmaceuticals LP | 2 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: Ozempic, OTEZLA, CAPLYTA, VOQUEZNA, KRYSTEXXA, BREZTRI, XIFAXAN, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
